| scholarly article | Q13442814 |
| P50 | author | Michael Manns | Q1564831 |
| Tobias J. Weismüller | Q45899974 | ||
| Justyna Siwy | Q56812289 | ||
| Petra Zürbig | Q61800394 | ||
| Eric Schiffer | Q112735778 | ||
| Harald Mischak | Q37828676 | ||
| Kathrin Thedieck | Q39372635 | ||
| Jochen Metzger | Q42413978 | ||
| P2093 | author name string | Ralf Baumeister | |
| Eva M Weissinger | |||
| Tim O Lankisch | |||
| Jochen Wedemeyer | |||
| Ahmed A Negm | |||
| Andrea S Schneider | |||
| Katja Vosskuhl | |||
| P2860 | cites work | Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach | Q46795489 |
| Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers | Q47399384 | ||
| Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis | Q48516720 | ||
| Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. | Q51767427 | ||
| Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. | Q53524243 | ||
| Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. | Q53635431 | ||
| Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. | Q55042580 | ||
| Urinary Proteomic Biomarkers in Coronary Artery Disease | Q56970751 | ||
| Proteomic Analysis of Human Bile from Malignant Biliary Stenosis Induced by Pancreatic Cancer | Q57914301 | ||
| Comprehensive Proteomic Analysis of Human Pancreatic Juice | Q57979970 | ||
| Assessment of serum and bile levels of CA19-9 and CA125 in cholangitis and bile duct carcinoma | Q68259807 | ||
| Two-dimensional electrophoretic analysis of vesicular and micellar proteins of gallbladder bile | Q73671308 | ||
| Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction | Q73691957 | ||
| A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures | Q74148537 | ||
| Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis | Q80033857 | ||
| Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma | Q80587726 | ||
| Epithelial-mesenchymal transition and its implications for fibrosis | Q24302042 | ||
| The human plasma proteome: history, character, and diagnostic prospects | Q28218148 | ||
| A proteomic analysis of human bile | Q28256550 | ||
| Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics | Q29615818 | ||
| Structure and function of inter-alpha-trypsin inhibitor heavy chains. | Q30373164 | ||
| Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis | Q30439686 | ||
| Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry | Q31038387 | ||
| Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation | Q33241474 | ||
| Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins | Q33307093 | ||
| Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma | Q33947189 | ||
| 14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation | Q33951080 | ||
| Hepatic and extrahepatic malignancies in primary sclerosing cholangitis | Q33957644 | ||
| Cholangiocarcinoma. | Q33990595 | ||
| Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery | Q34400055 | ||
| Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments | Q34809065 | ||
| The 14-3-3 cancer connection | Q35635340 | ||
| Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review | Q36943808 | ||
| The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment | Q37028526 | ||
| Trends in CE-MS 2005-2006. | Q37045725 | ||
| Circulating markers of biliary malignancy: opportunities in proteomics? | Q37073078 | ||
| The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy | Q37096344 | ||
| Acute phase proteins in atherosclerosis (acute coronary syndrome). | Q37294191 | ||
| Serum and bile biomarkers for cholangiocarcinoma | Q37461212 | ||
| Proteomic analysis of human bile and potential applications for cancer diagnosis. | Q37505061 | ||
| ANXA8 down-regulation by EGF-FOXO4 signaling is involved in cell scattering and tumor metastasis of cholangiocarcinoma. | Q39859456 | ||
| Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway | Q45234630 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholangiocarcinoma | Q124292 |
| ascending cholangitis | Q603644 | ||
| sclerosing cholangitis | Q18554727 | ||
| primary sclerosing cholangitis | Q1058608 | ||
| choledocholithiasis | Q9290860 | ||
| P304 | page(s) | 875-884 | |
| P577 | publication date | 2011-01-03 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis | |
| P478 | volume | 53 |
| Q41303036 | A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin |
| Q39160195 | A comparative proteomic analysis of bile for biomarkers of cholangiocarcinoma |
| Q100750450 | A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy |
| Q38595049 | A shift in paradigm towards human biology-based systems for cholestatic-liver diseases. |
| Q26784091 | An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma |
| Q33605089 | Angiopoietin-2 and biliary diseases: elevated serum, but not bile levels are associated with cholangiocarcinoma |
| Q45971399 | Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis. |
| Q38199367 | Application of capillary electrophoresis for the early diagnosis of cancer |
| Q92404951 | Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma |
| Q38201380 | Bile proteome in health and disease. |
| Q35580127 | Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study |
| Q38130203 | Biliary proliferative lesions in the Sprague-Dawley rat: adverse/non-adverse |
| Q26998582 | Biliary strictures: diagnostic considerations and approach |
| Q38434946 | Biomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures |
| Q38213808 | CE-ESI-MS for bottom-up proteomics: Advances in separation, interfacing and applications |
| Q38340358 | CE-MS-based proteomics in biomarker discovery and clinical application |
| Q38340351 | Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics |
| Q46087686 | Cholangiocarcinoma - evolving concepts and therapeutic strategies |
| Q37714579 | Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development |
| Q38273868 | Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. |
| Q34464452 | Comparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma |
| Q99558400 | Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers |
| Q31081531 | Detection of IGF2BP3, HOXB7, and NEK2 mRNA expression in brush cytology specimens as a new diagnostic tool in patients with biliary strictures |
| Q43906599 | Different expression of S100A8 in malignant and benign gallbladder diseases |
| Q57120312 | Emerging Technologies for the Diagnosis of Perihilar Cholangiocarcinoma |
| Q38384848 | Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies |
| Q38622793 | Evaluation of indeterminate biliary strictures |
| Q37957967 | Evolving concepts in primary sclerosing cholangitis |
| Q34098435 | Extracellular vesicle noncoding RNA: new players in the diagnosis and pathogenesis of cholangiocarcinoma |
| Q38798747 | Greater Biosynthetic Liver Dysfunction in Primary Sclerosing Cholangitis Suggests Co-existent or Impending Cholangiocarcinoma |
| Q26782878 | How Should Cancer Surveillance in Primary Sclerosing Cholangitis Be Performed? |
| Q57711927 | How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS |
| Q86169751 | Immunoglobulin G4-associated cholangitis: dominating immunoglobulin G4-positive clones within the B-cell receptor repertoire indicate light at the end of a long tunnel |
| Q47290643 | Indeterminate biliary strictures: a simplified approach |
| Q92591376 | Investigation of 23 Bile Acids in Liver Bile in Benign and Malignant Biliary Stenosis: A Pilot Study |
| Q46020758 | Lipidomic profiling of bile in distinguishing benign from malignant biliary strictures: a single-blinded pilot study. |
| Q39013668 | Mass spectrometry-based proteomic analysis of formalin-fixed paraffin-embedded extrahepatic cholangiocarcinoma |
| Q35796897 | MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma |
| Q27015831 | Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management |
| Q90400187 | Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis |
| Q91755162 | Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: The past, the present, and the future |
| Q90432003 | Possible Mechanisms by Which Enzymatic Degradation of Human Serum Albumin Can Lead to Bioactive Peptides and Biomarkers |
| Q36199767 | Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management |
| Q38107484 | Primary Sclerosing Cholangitis: Current and Future Management Strategies |
| Q56442936 | Primary sclerosing cholangitis |
| Q38485235 | Primary sclerosing cholangitis: a clinical update |
| Q38077820 | Primary sclerosing cholangitis: a review and update on therapeutic developments |
| Q26829216 | Primary sclerosing cholangitis: diagnosis and treatment |
| Q34429098 | Proteomic identification of plasma protein tyrosine phosphatase alpha and fibronectin associated with liver fluke, Opisthorchis viverrini, infection |
| Q48031735 | Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation |
| Q94526745 | Quantitative proteomic analysis of bile in extrahepatic cholangiocarcinoma patients |
| Q38596722 | Recent applications of CE- and HPLC-MS in the analysis of human fluids |
| Q42406650 | Recent developments in the management of idiopathic cholestatic liver disease |
| Q26740434 | Risk and Surveillance of Cancers in Primary Biliary Tract Disease |
| Q34130667 | S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis |
| Q48553032 | Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. |
| Q27013772 | Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review |
| Q36683019 | The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer |
| Q47587893 | The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome |
| Q51455474 | The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation. |
| Q34342199 | Treatment of autoimmune liver disease: current and future therapeutic options |
| Q92610705 | Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis |
| Q82517154 | [Treatment of autoimmune liver diseases. Autoimmune hepatitis and primary sclerosing cholangitis] |
Search more.